Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
New research suggests power of zebrafish as tool for cancer drug discovery

New research suggests power of zebrafish as tool for cancer drug discovery

CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL

CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL

New guidance for treatment of bone loss in hematologic stem cell transplant Recipients

New guidance for treatment of bone loss in hematologic stem cell transplant Recipients

Scientists explore whether seafood could be the source of next anti-cancer drug

Scientists explore whether seafood could be the source of next anti-cancer drug

FDA approves new treatment for people with hairy cell leukemia

FDA approves new treatment for people with hairy cell leukemia

Study: Children with acute lymphoblastic leukemia are immunologically disparate at birth

Study: Children with acute lymphoblastic leukemia are immunologically disparate at birth

Scientists get unprecedented view of brain development through high-resolution genomic map

Scientists get unprecedented view of brain development through high-resolution genomic map

Novel treatment for hairy cell leukemia approved by FDA

Novel treatment for hairy cell leukemia approved by FDA

Drug combination targets pre-leukemia stem cells

Drug combination targets pre-leukemia stem cells

New study links stress with biological disease markers in leukemia patients

New study links stress with biological disease markers in leukemia patients

Scientists develop first DNA-based test for predicting risk of leukemia relapse

Scientists develop first DNA-based test for predicting risk of leukemia relapse

Researchers identify new cancerous cells responsible for acute myeloid leukemia relapse

Researchers identify new cancerous cells responsible for acute myeloid leukemia relapse

Cancer Australia releases new data on childhood cancer stage at diagnosis

Cancer Australia releases new data on childhood cancer stage at diagnosis

Verastem doses first patient in Phase I/II clinical trial of duvelisib in combination with venetoclax

Verastem doses first patient in Phase I/II clinical trial of duvelisib in combination with venetoclax

New system accelerates discovery of chemical compounds that inhibit enzyme implicated in cancers

New system accelerates discovery of chemical compounds that inhibit enzyme implicated in cancers

Research shows new way to target drug delivery for brain tumors

Research shows new way to target drug delivery for brain tumors

Researchers identify enzyme that plays vital role in sexual development of fungi

Researchers identify enzyme that plays vital role in sexual development of fungi

Scientists identify 'Achilles heel' of anaplastic large-cell lymphomas

Scientists identify 'Achilles heel' of anaplastic large-cell lymphomas

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

Californians living longer with cancer — some longer than others

Californians living longer with cancer — some longer than others

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.